IQCF5 inhibitors are a specialized class of chemical compounds that specifically target and modulate the activity of the IQCF5 protein. IQCF5 is a member of the IQ motif-containing protein family, which is characterized by the presence of one or more IQ motifs-regions that are typically associated with calmodulin-binding properties. These proteins play roles in various cellular processes, including signal transduction and intracellular calcium regulation. IQCF5 inhibitors are designed to selectively interact with the IQCF5 protein, disrupting its normal function and leading to alterations in the downstream signaling pathways it regulates. By focusing on IQCF5, these inhibitors can serve as valuable tools for understanding the protein's biochemical role within cellular processes.
The structural design of IQCF5 inhibitors often involves a high degree of specificity, achieved through molecular modeling and structure-activity relationship (SAR) studies. These compounds can be small molecules or peptides that are engineered to bind precisely to active or allosteric sites on the IQCF5 protein. Their interaction may result in competitive inhibition, where the inhibitor directly competes with natural ligands for the binding site, or non-competitive inhibition, which alters the protein's conformation or functionality without directly blocking ligand binding. Inhibition of IQCF5 can lead to various downstream cellular effects, such as changes in calcium-dependent signaling, gene expression, or protein-protein interactions. The study of these inhibitors provides valuable insights into the complex regulation mechanisms of IQ motif-containing proteins and their broader biological significance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum kinase inhibitor, potentially affecting various signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a kinase involved in many cellular processes, potentially impacting protein expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, potentially affecting signaling pathways related to protein expression and function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, known to affect signaling pathways influencing protein expression and activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis, potentially affecting the overall expression of proteins including IQCF5. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport within cells, potentially impacting protein processing and function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor, could influence the degradation and turnover of proteins. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Inhibits autophagy, potentially affecting protein degradation and cellular homeostasis. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
HSP90 inhibitor, potentially affecting protein folding and stability. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, could indirectly influence signaling pathways and protein functions. | ||||||